Trials / Completed
CompletedNCT04662814
Extracorporeal Shock Wave Therapy for Dysmenorrhea
the Efficacy of Extracorporeal Shock Wave Therapy for Primary Dysmenorrhea
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- MTI University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea
Detailed description
This randomized controlled trial is to determine the effect of shock wave therapy in the treatment of primary dysmenorrhea. females are randomly assigned into 2 groups: group A SWT treatment plus dietary modification during PD (n=25) GROUP B:dietary modification only (n=25); Participants in group B will receive dietary modification for three successive months The numerical rating scale (NRS) and prostaglandin blood level will be recorded and evaluated before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | shock wave therapy | Intervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods. |
| OTHER | dietary modification | Participants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months |
Timeline
- Start date
- 2020-09-12
- Primary completion
- 2020-12-24
- Completion
- 2021-01-27
- First posted
- 2020-12-10
- Last updated
- 2021-03-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04662814. Inclusion in this directory is not an endorsement.